
Parkinson's disease (PD) is a common neurodegenerative disease diagnosed based on its cardinal motor features. Many PD patients experience non-motor symptoms, including cognitive decline, which can be particularly debilitating. Fluid biomarkers in PD are lacking, but modern proteomic techniques have allowed for high-throughput studies which have generated promising results. Mass spectrometry provides an unbiased approach to biomarker discovery, and the plasma proteome reflects ongoing disease processes throughout the body, including the central nervous system. Plasma samples from 198 individuals (130 PD and 68 controls) from the Swedish Biopark cohort were TMT-tagged, pre-fractionated, and analysed using untargeted mass spectrometry. Robust peptides from candidate biomarkers were technically verified using parallel reaction monitoring (PRM). The analyses focused on PD diagnosis and cognitive decline. Results were compared with plasma Neurofilament light chain levels analysed on the SIMOA platform. Several promising candidate biomarkers were discovered for PD diagnosis, cognitive decline, and motor impairment in the discovery phase. Peptides from six of the 12 proteins quantified with PRM correlated with quantifications from the discovery phase. Following PRM verification, it was found that peptides from C9 and APOC3 had altered levels in PD compared with controls. Additionally, SAA1 was found to be associated with both cognitive and motor impairment. Neurofilament light chain levels were elevated in PD with cognitive impairment but showed a weaker correlation with cognitive function than SAA1. In conclusion, untargeted mass spectrometry is a viable method for generating novel candidate biomarkers in PD plasma, several of which were technically verified with PRM including SAA1, C9, and APOC3.
Brain aging is a spatially heterogeneous and multi-layered process, yet how protein abundance and post-translational modifications (PTMs) are coordinated across brain regions and over time remains incompletely understood. Here, we present a brain-region-resolved, multi-layer proteomics atlas of mouse brain aging, integrating the proteome, phosphoproteome, acetylome, and ubiquitinome across 11 anatomical regions and five time points spanning from young adulthood to senescence. Using dia-PASEF with PTM-optimized acquisition, we quantified 11,460 proteins with 29,225 phosphorylation sites, 5345 acetylation sites, and 5197 ubiquitination sites across 628 injections, enabling systematic analysis of age-associated molecular trajectories. We find that aging patterns are highly region-specific at both the protein and PTM levels, and the pons emerges as a region with marked phosphorylation-level alterations in aging-related signaling pathways. Notably, we uncover a proteostasis-centered regulatory axis in the aging hippocampus, where reduced ubiquitination and increased acetylation converge on Tau, potentially impairing its degradation. Using a telomerase-deficient mouse model (Tert KO), we show that telomere dysfunction perturbs aging-associated molecular trajectories and induces a divergent proteostasis and stress-response state distinct from physiological brain aging. Together, our study provides a spatiotemporal multi-layer proteomics resource of brain aging and reveals a proteostasis-centered landscape of post-translational remodeling associated with region-specific vulnerability and Tau dysregulation.
Archival formalin-fixed paraffin-embedded (FFPE) tissue is the largest clinically annotated human biospecimen resource, yet proteomic analysis of low-input microdissected regions remains limited. We performed a streamlined workflow enabling deep proteome coverage from laser-microdissected archival FFPE kidney tissue using standard laboratory infrastructure. We systematically compared extraction with n-dodecyl-β-D-maltoside followed by single-pot, solid-phase-enhanced sample preparation (DDM + SP3), detergent-free triethylammonium bicarbonate followed by SP3 cleanup (TEAB + SP3), and direct TEAB processing without offline bead-based cleanup. Across the experimental conditions evaluated, elimination of detergent-based cleanup was associated with increased proteome depth in low-input FFPE samples. A direct TEAB workflow reproducibly yielded up to 5500 proteins from 27000 μm2 microdissected regions of decade-old biopsies. Hydrophobicity profiling and functional enrichment analyses showed similar physicochemical and cellular-compartment coverage across workflows, with no evidence of major workflow-associated bias under the conditions evaluated. Comparable proteome coverage was observed across platforms, although not directly controlled due to differences in liquid chromatography-mass spectrometry (LC-MS) configuration. The required input corresponds to common microanatomical units and does not rely on automation or specialized microfluidics. This workflow provides an accessible framework for compartment-resolved proteomics in kidney tissue, enabling retrospective and rare-disease proteomic research from long-term FFPE repositories. Further studies are needed to assess our workflow's applicability to other scarce archival specimens.